Keywords: profits, up, nycomed, norwegian, pharmaceutical, company, hafslund
PROFITS UP 17% IN 1992 AT NYCOMED
Article | 15 February 1993
Norwegian pharmaceutical company Hafslund Nycomed achieved 1992 profits before extraordinary items of 1.5 billion Norwegian kroner ($215.8 million), an increase of 17% on the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
